Go to the page content

Are you aware of cardiovascular risk?

People with type 2 diabetes are 2-4 times more likely to have a heart attack or stroke compared to someone living without diabetes1,2,3.


Learn how you can reduce the risk.

Marta, living with type 2 diabetes

“If only I had known then what I know now about diabetes complications, then maybe my heart attack could have been prevented.”

-Marta, living with type 2 diabetes

Providing you the tools to manage diabetes

In these sections, you can find more information on diabetes, lifestyle tips and treatments.

About diabetes

About diabetes

Read more about diabetes in general and the different types of diabetes. In this section we cover what you need to know as a caregiver or a person living with diabetes.

Living with diabetes

Living with diabetes

How do you manage your lifestyle when it comes to diabetes? Whether it be nutrition or exercise, we have gathered tips and articles to help you manage diabetes.

Treatment of diabetes
1 min. read

Treatment of diabetes

There are multiple ways to treat diabetes. Lifestyle, insulin, and alternatives to insulin all play key roles in living with type 1 and type 2 diabetes.

Question 1 of 6

Diabetes Mythbusting

Millions of people are living with diabetes worldwide, approximately 90% of whom suffer from type 2 diabetes4. Despite its prevalence, many myths still persist. At Novo Nordisk, we’re committed to improving awareness and treatment for everyone at risk of diabetes across the globe.

Myth #1

Blood sugar is the only important factor when it comes to managing diabetes.

It is also important to manage weight, diet and exercise⁴.

Myth #2

Type 2 diabetes can be cured with lifestyle therapy alone.

As a progressive disease, medication is often required.

Myth #3

Treatments for type 2 diabetes only target blood sugar.

Some treatments can also reduce the risk of heart disease.

Myth #4

People with type 2 diabetes are at higher risk of cardiovascular disease.

9 in 10 people with type 2 diabetes face higher risk¹.

Myth #5

Insulin therapy is the only viable option for type 2 diabetics.

Insulin is just one of many types of diabetes treatments⁴.

Myth #6

The human body has a naturally occurring hormone called GLP-1 that helps manage blood sugar and regulate appetite.

GLP-1 is a naturally occurring hormone that manages blood sugar and regulates appetite⁵.

Bad Luck

You learn more from defeat than victory! Better luck next time.

Good Work

Not bad at all! Still some room for improvement.

Excellent

You're an expert mythbuster! Time to challenge your friends.

Blood sugar is the only important factor when it comes to managing diabetes.

Correct

While blood sugar is a key part of diabetes management, there are a number of risk factors that influence your long-term health, including weight, diet, and exercise. Staying in control help reduce your risk of cardiovascular events such as heart attacks and strokes.



Learn more about monitoring blood sugar
Type 2 diabetes can be cured with lifestyle therapy alone.

Correct

Type 2 diabetes is a progressive disease, meaning your condition will evolve over time. And faster if left untreated. While diet and exercise can help stabilise your condition, at some stage, diabetes will require prescribed medication to help balance your metabolism and blood sugar.



Learn more about balancing lifestyle factors and medication
Treatments for type 2 diabetes only target blood sugar.

Correct

Balancing blood glucose is important as type 2 diabetes impairs the body's natural ability to produce insulin. However, treatments should also address heightened risk factors like cardiovascular disease, the leading cause of death for people with type 2 diabetes.



Learn more about diabetes and heart disease
People with type 2 diabetes are at higher risk of cardiovascular disease.

Correct

People living with type 2 diabetes face higher risk of cardiovascular disease, even if symptoms aren't apparent. Ask your doctor about glucose-lowering, cardio-protective treatment options.



Learn more about cardiovascular risk
Insulin therapy is the only viable option for type 2 diabetics.

Correct

There are several non-insulin diabetes treatments available, such as Metformin, Sulfonylureas, SGLT-2 inhibitors, and GLP-1 receptor agonists. As diabetes progresses, it may be necessary to start on one treatment or a combination of two or more.



Learn more about non-insulin treatment options
The human body has a naturally occurring hormone called GLP-1 that helps manage blood sugar and regulate appetite.

Correct

GLP-1, or glucagon-like peptide-1, helps your body release its own insulin and is designed to respond when your blood sugar rises. It also slows down food leaving your stomach and helps reduce the amount of sugar released from your liver.



Learn more about GLP-1 and how it works

It’s better to catch things before they become a problem

Type 2 diabetes & CVD
2 min. read

Type 2 diabetes & CVD

How do you prevent cardiovascular disease with type 2 diabetes?

Latest insights

Type 2 diabetes

Type 2 diabetes

How to prevent and control type 2 diabetes through exercise, a balanced diet, and other treatment options.

HQ24DI00008

References
  1. Mosenzon O, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021; 20:154.
  2. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164:1422–1426.
  3. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004; 292:2495–2499.
  4. International Diabetes Federation. IDF Atlas 10th Edition, 2021. Available from: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf. Last accessed: May 2022.
  5. MacDonald PE, El-kholy W, Riedel MJ, et al. The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion. Diabetes. 2002;51:S434-S442. doi: 10.2337/diabetes.51.2007.S434.